苏州旺山旺水生物医药股份有限公司（“旺山旺水-B”，股票代码：02630）于2026年3月5日发布截至2026年2月28日的股份变动月报表。报告显示，公司当月无新增发行、购回或注销股份，整体股本保持稳定。
公司已发行H股数量维持为66,677,133股，面值1元人民币，总注册股本为人民币66,677,133元；非上市股份数量则维持在100,920,667股，面值同为1元人民币，对应注册股本人民币100,920,667元。截至报告期末，公司注册股本总额为人民币167,597,800元。
公告未披露任何股份期权相关变动、购回及注销活动，也无任何可转换债券、认股权证或其他协议安排的变动信息。公司确认，当前已符合相关上市规则及法律法规对公众持股量的要求。
本次月报由董事会秘书兼联席公司秘书郭婷签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.